You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis
|
|---|---|
| Published in |
BMC Cancer, October 2019
|
| DOI | 10.1186/s12885-019-6132-0 |
| Pubmed ID | |
| Authors |
Shanshan Chen, Yu Liang, Zhangying Feng, Mingxia Wang |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Italy | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 99 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 15% |
| Other | 12 | 12% |
| Student > Bachelor | 12 | 12% |
| Student > Master | 11 | 11% |
| Student > Postgraduate | 7 | 7% |
| Other | 15 | 15% |
| Unknown | 27 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 15% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Economics, Econometrics and Finance | 4 | 4% |
| Nursing and Health Professions | 3 | 3% |
| Other | 10 | 10% |
| Unknown | 33 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2022.
All research outputs
#6,996,768
of 22,925,760 outputs
Outputs from BMC Cancer
#1,847
of 8,333 outputs
Outputs of similar age
#129,022
of 356,317 outputs
Outputs of similar age from BMC Cancer
#33
of 166 outputs
Altmetric has tracked 22,925,760 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 8,333 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,317 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 166 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.